IRVINE SENSORS CORP/DE/
10-Q/A, 1996-03-20
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CONNECTICUT MUTUAL INVESTMENT ACCOUNTS INC, 497, 1996-03-20
Next: FIRST BANKING CO OF SOUTHEAST GEORGIA, PRE 14A, 1996-03-20



<PAGE>
 
                        SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C. 20549

                                  FORM 10-Q/A
(Mark One)
[X]    QUARTERLY REPORT PURSUANT TO SECTION  13 OR 15(d) OF THE
       SECURITIES EXCHANGE ACT OF 1934

       For the quarterly period ended December 31, 1995

                                        OR

[_]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
       THE SECURITIES EXCHANGE ACT OF 1934

       For the Transition period from __________ to __________

                        Commission file number   1-8402
                                                ---------



                            IRVINE SENSORS CORPORATION
              (Exact name of registrant as specified in its charter)


              Delaware                                 33-0280334
  (State or other jurisdiction of                     (IRS Employer
   incorporation or organization)                  Identification No.)


                   3001 Redhill Avenue, Costa Mesa, California
                     (Address of principal executive offices)

                                      92626
                                    (Zip Code)

                                  (714) 549-8211
               (Registrant's telephone number, including area code)



     Indicate by check mark whether the  registrant  (1)  has filed all reports
required  to  be   filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12   months (or  for such  shorter  period that the
registrant  was  required  to file such reports),   and (2) has been subject to
such filing requirements for the past 90 days.

                          Yes  X              No
                             -----              -----     

          As of December 31, 1995 there were 16,028,300 shares of Common Stock
outstanding.
<PAGE>
 
                                    PART II

                               OTHER INFORMATION


Item 6.  Exhibits and Reports on Form 8-K
         --------------------------------

   (a) Exhibits.

       Exhibit 27.1  Financial Data Schedule

                                       2
<PAGE>
 
                                 SIGNATURES
                                 ----------



Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



                                   IRVINE SENSORS CORPORATION
                                   
                                   ----------------------------------------
                                   (Registrant)



Date: March 19, 1996               By:     /s/ John J. Stuart, Jr.
                                   -------------------------------------------- 
                                   John J. Stuart, Jr.
                                   Chief Financial Officer
                                   (Principal Accounting Officer)


                                       3
<PAGE>
 
                                 EXHIBIT INDEX

<TABLE> 
<CAPTION> 
    EXHIBIT NO.                     DESCRIPTION OF EXHIBIT
    -----------                     ----------------------
    <C>           <S>
    27.1          Financial Data Schedule

</TABLE> 

<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND> 
This schedule contains summary financial information extracted from 
1st Quarter 10-Q and is qualified in its entirety by reference to such
financial statements. 
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-29-1996
<PERIOD-START>                             OCT-02-1996
<PERIOD-END>                               DEC-31-1995
<CASH>                                       1,173,100
<SECURITIES>                                         0
<RECEIVABLES>                                2,988,800
<ALLOWANCES>                                    10,000
<INVENTORY>                                  4,285,400
<CURRENT-ASSETS>                             8,653,900
<PP&E>                                      10,814,300
<DEPRECIATION>                               4,829,600
<TOTAL-ASSETS>                              14,668,700
<CURRENT-LIABILITIES>                        3,229,200
<BONDS>                                        150,000
<COMMON>                                       160,300
                              200
                                          0
<OTHER-SE>                                  10,678,500
<TOTAL-LIABILITY-AND-EQUITY>                14,668,700
<SALES>                                      2,506,500
<TOTAL-REVENUES>                             2,578,500
<CGS>                                        2,613,600
<TOTAL-COSTS>                                3,855,500
<OTHER-EXPENSES>                               372,400
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              34,500
<INCOME-PRETAX>                            (1,272,300)
<INCOME-TAX>                                       900
<INCOME-CONTINUING>                        (1,273,200)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,273,200)
<EPS-PRIMARY>                                   (0.08)
<EPS-DILUTED>                                   (0.08)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission